BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37910818)

  • 1. Impact of Social Disparities on 5-Year Survival Rates in Pediatric Hematologic Malignancies.
    Chalfant V; Riveros C; Bechtel A; Bradfield SM; Stec AA
    J Pediatr Hematol Oncol; 2024 Jan; 46(1):33-38. PubMed ID: 37910818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004.
    Pulte D; Gondos A; Brenner H
    J Natl Cancer Inst; 2008 Sep; 100(18):1301-9. PubMed ID: 18780868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of pediatric hematological malignancies in Kazakhstan: Data from Unified National Electronic Healthcare System 2014-2021.
    Mussina K; Kuanova B; Syssoyev D; Gaipov A; Poddighe D; Shaikhyzada K; Aimyshev T; Galiyeva D
    Eur J Pediatr; 2024 Apr; 183(4):1683-1691. PubMed ID: 38214809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Haematological malignancies: incidence in Basse-Normandie, France, for 1997-2004].
    Troussard X; Duchenet V; Cornet E; Mouchel D; Malet M; Collignon A
    Rev Epidemiol Sante Publique; 2009 Jun; 57(3):151-8. PubMed ID: 19375876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in long term survival after diagnosis with common hematologic malignancies in the early 21st century.
    Pulte D; Jansen L; Brenner H
    Blood Cancer J; 2020 May; 10(5):56. PubMed ID: 32404891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of social disparities on 10 year survival in pediatric patients with Wilms' tumor.
    Chalfant V; Riveros C; Stec AA
    Cancer Med; 2023 Feb; 12(3):3452-3459. PubMed ID: 35946133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nationwide Statistical Analysis of Lymphoid Malignancies in Korea.
    Lee H; Park HJ; Park EH; Ju HY; Oh CM; Kong HJ; Jung KW; Park BK; Lee E; Eom HS; Won YJ
    Cancer Res Treat; 2018 Jan; 50(1):222-238. PubMed ID: 28361523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicoepidemiological profiles, clinical practices, and the impact of holistic care interventions on outcomes of pediatric hematolymphoid malignancies - A 7-year audit of the pediatric hematolymphoid disease management group at Tata Memorial Hospital.
    Narula G; Prasad M; Jatia S; Subramanian PG; Patkar N; Tembhare P; Shetty D; Khanna N; Laskar S; Shet T; Epari S; Kembhavi S; Shah S; Qureshi S; Gujral S; Banavali SD
    Indian J Cancer; 2017; 54(4):609-615. PubMed ID: 30082544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005.
    Pulte D; Gondos A; Brenner H
    Cancer; 2009 Nov; 115(21):4973-9. PubMed ID: 19705347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family history of cancer in children with acute leukemia, Hodgkin's lymphoma or non-Hodgkin's lymphoma: the ESCALE study (SFCE).
    Rudant J; Menegaux F; Leverger G; Baruchel A; Nelken B; Bertrand Y; Hartmann O; Pacquement H; Vérité C; Robert A; Michel G; Margueritte G; Gandemer V; Hémon D; Clavel J
    Int J Cancer; 2007 Jul; 121(1):119-26. PubMed ID: 17330239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Social Deprivation Associated with PROMIS Outcomes After Upper Extremity Fractures in Children?
    Evans S; Okoroafor UC; Calfee RP
    Clin Orthop Relat Res; 2021 Apr; 479(4):826-834. PubMed ID: 33196588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does serum soluble vascular endothelial growth factor levels have different importance in pediatric acute leukemia and malignant lymphoma patients?
    Dincaslan HU; Yavuz G; Unal E; Tacyildiz N; Ikinciogullari A; Dogu F; Guloglu D; Yuksek N; Ertem U
    Pediatr Hematol Oncol; 2010 Oct; 27(7):503-16. PubMed ID: 20677920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost of Disease Progression in Patients with Chronic Lymphocytic Leukemia, Acute Myeloid Leukemia, and Non-Hodgkin's Lymphoma.
    Reyes C; Engel-Nitz NM; DaCosta Byfield S; Ravelo A; Ogale S; Bancroft T; Anderson A; Chen M; Matasar M
    Oncologist; 2019 Sep; 24(9):1219-1228. PubMed ID: 30808814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global burden of hematologic malignancies and evolution patterns over the past 30 years.
    Zhang N; Wu J; Wang Q; Liang Y; Li X; Chen G; Ma L; Liu X; Zhou F
    Blood Cancer J; 2023 May; 13(1):82. PubMed ID: 37193689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of rasburicase over standard of care for the prevention and treatment of tumor lysis syndrome in children with hematologic malignancies in China.
    Hu S; Han Y; Zhang W; Zhang T; Yao X; Liu L
    J Med Econ; 2019 Aug; 22(8):742-750. PubMed ID: 30939962
    [No Abstract]   [Full Text] [Related]  

  • 17. Childhood hematopoietic malignancies and parental use of tobacco and alcohol: the ESCALE study (SFCE).
    Rudant J; Menegaux F; Leverger G; Baruchel A; Lambilliotte A; Bertrand Y; Patte C; Pacquement H; Vérité C; Robert A; Michel G; Margueritte G; Gandemer V; Hémon D; Clavel J
    Cancer Causes Control; 2008 Dec; 19(10):1277-90. PubMed ID: 18618277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Incidence of neoplasms of the hematologic and lymphoreticular systems in Lower Silesia 1972-1985. I. Incidence in the entire region].
    Kotlarek-Haus S; Waszkiewicz L; Kin-Dittmann I; Błaczkowska A
    Acta Haematol Pol; 1990; 21(2):173-84. PubMed ID: 2131717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of ABO blood groups in acute leukaemias and lymphomas.
    Vadivelu MK; Damodaran S; Solomon J; Rajaseharan A
    Ann Hematol; 2004 Sep; 83(9):584-7. PubMed ID: 15175895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in the curative treatment of childhood hematologic malignancies.
    Wayne AS; Reaman GH; Helman LJ
    J Natl Cancer Inst; 2008 Sep; 100(18):1271-3. PubMed ID: 18780861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.